Mexiletine dosing and tolerability in refractory chronic migraine: Insights from post-lidocaine infusion treatment
Background Mexiletine is used as a preventive medication for refractory chronic migraine (rCM) and to prolong migraine improvement following intravenous lidocaine infusion. However, published evidence supporting its use in migraine remains limited. This retrospective study describes the dosing, trea...
Saved in:
| Main Authors: | Lucia Liao, Hsiangkuo Yuan, Dylan Selbst, Emily Casaletto, Jiangang Liao, Clinton G. Lauritsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Cephalalgia Reports |
| Online Access: | https://doi.org/10.1177/25158163241313123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dyskinesia due to mexiletine overdose: a rare presentation
by: Zeynelabidin Öztürk, et al.
Published: (2023-08-01) -
Lidocaine Infusion as a Rescue Analgesic in the Perioperative Setting
by: C Clarke, et al.
Published: (2008-01-01) -
Effects and predictors of intravenous lidocaine infusion for patients with fibromyalgia.
by: Min Liu, et al.
Published: (2025-01-01) -
Effects and predictors of intravenous lidocaine infusion for patients with fibromyalgia
by: Min Liu, et al.
Published: (2025-01-01) -
Mexiletine in the Treatment of LQT2, LQT3, and Acquired LQTS: A Meta-Analysis
by: Dhiya Ihsan, et al.
Published: (2025-05-01)